EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark REGENXBIO was filed as Word mark on 10/01/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/24/2015.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 013315403 |
| Application date | October 1, 2014 |
| Publication date | November 17, 2014 |
| Entry date | February 24, 2015 |
| Expiration date | October 1, 2034 |
Trademark owner
9804 Medical Center Drive
20850 Rockville
US
20850 Rockville
US
Trademark representatives
23/31 boulevard Romain Rolland
75014 PARIS
FR
goods and services
42
Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy; Scientific and medical research and development; Genetic engineering services, biotechnology services, and research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 24, 2024 | Extension, Trade mark renewed | ||
| April 16, 2024 | Change Representative, Published | ||
| August 17, 2022 | Change Representative, Published | ||
| June 28, 2021 | Transfer / Change of address, Published | ||
| January 8, 2020 | Transfer / Change of address, Published | ||
| May 15, 2015 | Transfer / Change of address, Published |
ID: 11013315403